Heliyon (2023) 9(10):e20317
These formulations focus on replenishing electrolytes, reducing inflammation, and supporting muscle recovery
Product Details Active Ingredient : Bremelanotide (PT-141) Concentration : 20 mg per vial (lyophilized powder) Administration : Subcutaneous injection after reconstitution Volume : Reconstituted per provider instruction (typically 12 mL bacteriostatic water) Use : For clinical and research use under medical supervision Storage : Store lyophilized powder at 28C (3646F)
Data analysed by one-way ANOVA, multiple comparison, Bonferroni post hoc test ( c , e , g , l , n , p , v , x and z ) and two-way repeated measures ANOVA to assess main effects of treatment ( i , j , q , s and t )
Do not expose to direct sunlight
The underlying mechanism of this phenomenon was down-regulation of ACAT1 and CD36 and ABCA1 up-regulation